Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional Study-Reference-Cited by-同舟云学术

Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional Study

Published:2023-08 Issue:4 Volume:21 Page:483-490
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Eule Corbin J.^ORCID,Hu Junxiao,Al-Saad Sulaiman,Collier Katharine^ORCID,Boland Patrick^ORCID,Lewis Akeem R.^ORCID,McKay Rana R.,Narayan Vivek^ORCID,Bosse Dominick,Mortazavi Amir^ORCID,Rose Tracy L.^ORCID,Costello Brian A.^ORCID,Bryce Alan H.^ORCID,Lam Elaine T.^ORCID

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference23 articles.

1. Neuroendocrine and aggressive-variant prostate cancer;Spetsieris;Cancers (Basel),2020

2. Neuroendocrine prostate cancer: subtypes, biology, and clinical outcomes;Aggarwal;J Natl Compr Canc Netw,2014

3. Clinical features of neuroendocrine prostate cancer;Conteduca;Eur J Cancer,2019

4. Proposed morphologic classification of prostate cancer with neuroendocrine differentiation;Epstein;Am J Surg Pathol,2014

5. Aggressive variants of castration-resistant prostate cancer;Beltran;Clin Cancer Res,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Complete Response to Combined Immunotherapy in a Patient with an ATM plus SF3B1 Mutation and a Moderate Tumor Mutational Burden with a High-Grade Treatment-Emergent Neuroendocrine Prostate Cancer: Case Report and Review of the Literature;Case Reports in Oncology;2024-08-29

2. Excellent Response to 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in a Patient with Treatment-Related Neuroendocrine Prostate Cancer with Urinary Retention and Rectal Obstruction: A Case Report;Yonago Acta Medica;2024